Hepion Pharmaceuticals Inc (HEPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,106 | -13,192 | -11,645 | -6,779 | -2,854 |
| Depreciation Amortization | N/A | 1,300 | 505 | 31 | 31 |
| Other Working Capital | 167 | -2,683 | -2,727 | -4,639 | -2,136 |
| Other Operating Activity | 4,821 | -3,641 | -3,197 | -3,158 | 1,342 |
| Operating Cash Flow | $-1,117 | $-18,216 | $-17,063 | $-14,546 | $-3,617 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | -600 | -600 | 0 | 0 |
| Investing Cash Flow | $N/A | $-600 | $-600 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 2,500 | N/A | N/A |
| Debt Repayment | -2,900 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 9,000 | 1,850 | 1,850 | 1,850 | 1,850 |
| Other Financing Activity | -803 | 2,500 | 0 | 0 | 0 |
| Financing Cash Flow | $5,297 | $4,350 | $4,350 | $1,850 | $1,850 |
| Exchange Rate Effect | N/A | 87 | 25 | 25 | 87 |
| Beginning Cash Position | 406 | 14,786 | 14,786 | 14,786 | 14,786 |
| End Cash Position | 4,586 | 406 | 1,497 | 2,115 | 13,106 |
| Net Cash Flow | $4,180 | $-14,380 | $-13,289 | $-12,671 | $-1,680 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,117 | -18,216 | -17,063 | -14,546 | -3,617 |
| Free Cash Flow | -1,117 | -18,216 | -17,063 | -14,546 | -3,617 |